NCT01837446View on ClinicalTrials.gov

Morphine Mouthwash for Management of Oral Mucositis in Patients With Head and Neck Cancer

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

July 31, 2012

Study Completion Date

October 31, 2012

Conditions
Stomatitis
Interventions
DRUG

2% morphine solution

DRUG

Magnesium aluminum hydroxide

DRUG

2% viscous lidocaine

DRUG

Diphenhydramine

Trial Locations (1)

81849-17395

Radiation Oncology Department, Seyed Al-Shohada Hospital, Isfahan

All Listed Sponsors
lead

Isfahan University of Medical Sciences

OTHER

NCT01837446 - Morphine Mouthwash for Management of Oral Mucositis in Patients With Head and Neck Cancer | Biotech Hunter | Biotech Hunter